BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15339416)

  • 1. [Clinical observation on Biyan Qingdu Granule and ambroxol hydrochloride in treating secretory otitis media].
    Guo Y; Sun XM
    Zhong Xi Yi Jie He Xue Bao; 2004 Jul; 2(4):277, 291. PubMed ID: 15339416
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of secretory otitis media with ambroxol].
    Sartoris A
    Acta Otorhinolaryngol Ital; 1987; 7 Suppl 16():51-60. PubMed ID: 3334304
    [No Abstract]   [Full Text] [Related]  

  • 3. [Incorporation of a stimulant of the synthesis and secretion of pulmonary surfactant (ambroxol) in the medical treatment of serous otitis].
    Calero del Castillo JB; Pérez Martínez F; Piqueras Pérez F; Redondo Luciáñez ER
    An Otorrinolaringol Ibero Am; 1988; 15(2):209-18. PubMed ID: 3389499
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of mucoregulating drugs in combined therapy of exudative otitis media].
    Pekarskiĭ SI
    Vestn Otorinolaringol; 2003; (2):32-3. PubMed ID: 12958859
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of dexamethasone combined with ambroxol hydrochloride on T-Cell subsets and hearing in patients with secretory otitis media.
    Xiaorong D; Li M; Xuefeng L; Jian H
    Pak J Pharm Sci; 2019 May; 32(3 Special):1437-1440. PubMed ID: 31551228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromhexine for otitis media with effusion.
    Roydhouse N
    N Z Med J; 1981 Nov; 94(696):373-5. PubMed ID: 7033848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incorporation of a stimulant of synthesis and secretion of a pulmonary surfactant (ambroxol) into the treatment of otitis serosa].
    Bautista Calero del Castillo J; Pérez Martínez F; Piqueras Pérez F; Redondo Luciáñez ER
    Acta Otorrinolaringol Esp; 1988; 39(1):61-4. PubMed ID: 3272269
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of trace elements in therapy of secretory otitis media; preliminary results].
    Passàli D; De Seta E; Ciferri G; Bianchini-Ciampoli M
    Clin Ter; 1983 Sep; 106(5):367-77. PubMed ID: 6685601
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ambroxol in etiotropic chemotherapy of pulmonary tuberculosis].
    Suslov VA; Burtseva SA; Levchenko GI
    Voen Med Zh; 2002 May; 323(5):43-4. PubMed ID: 12073838
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of sore throat pain with ambroxol-containing lozenges. Results of a pharmacy supported patient questionnaire].
    Gillissen A; Hinkel U
    Med Monatsschr Pharm; 2005 Nov; 28(11):399-403. PubMed ID: 16309023
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of mucolytic preparations (Mucosolvan) in selected diseases of the upper respiratory tract. Part II].
    Szmeja Z; Golusiński W; Mielcarek-Kuchta D; Laczkowska-Przybylska J
    Otolaryngol Pol; 1997; 51(5):480-6. PubMed ID: 9557050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter study on the treatment of secretory otitis media with ambroxol. Importance of a surface-tension-lowering substance.
    Passàli D; Zavattini G
    Respiration; 1987; 51 Suppl 1():52-9. PubMed ID: 3602599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of S-carboxymethyl-L-cysteine for otitis media with effusion.
    Steventon GB; Mitchell SC
    Ear Nose Throat J; 2006 May; 85(5):296-7. PubMed ID: 16771015
    [No Abstract]   [Full Text] [Related]  

  • 14. [Protective effects of ambroxol on lung injury during cardiacpulmonary bypass in patients undergoing valve replacement].
    Zhou HY; Chang YT; Lü ZP
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):723-4. PubMed ID: 16114570
    [No Abstract]   [Full Text] [Related]  

  • 15. Perioperative Lung Protection Provided by High-Dose Ambroxol in Patients with Lung Cancer.
    Wang X; Wang L; Wang H; Zhang H
    Cell Biochem Biophys; 2015 Nov; 73(2):281-284. PubMed ID: 25733331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Qing Qiao Capsule in the treatment of chronic secretory otitis media and the levels of serum inflammatory factors.
    Zhong L; Tan M; Hu W; Lv C; Zhu J; Liu J; Zhou X
    Cell Mol Biol (Noisy-le-grand); 2020 Apr; 66(1):109-113. PubMed ID: 32359393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and experimental study on treatment of acute catarrhal otitis media with eryanling oral liquid].
    Zhang H; Li S; Liu R
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Oct; 20(10):743-6. PubMed ID: 11938809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value exploration of treating pediatric pneumonia with ambroxol hydrochloride and procaterol hydrochloride.
    Liu X; Dong Y; Lv W
    Minerva Pediatr (Torino); 2024 Feb; 76(1):145-147. PubMed ID: 37335187
    [No Abstract]   [Full Text] [Related]  

  • 19. The additive effect on the antiepileptic treatment of ambroxol in type 3 Gaucher patient. The early observation.
    Pawlinski L; Malecki MT; Kiec-Wilk B
    Blood Cells Mol Dis; 2018 Feb; 68():192-193. PubMed ID: 28007403
    [No Abstract]   [Full Text] [Related]  

  • 20. The preventive effect of ambroxol hydrochloride chitosan on postoperative intraperitoneal adhesion formation in a rat model.
    Zhao JM; Jin ZZ; Zhao QZ
    Acta Chir Belg; 2017 Aug; 117(4):232-237. PubMed ID: 28636473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.